Third party terms – Patent GB2310274 was announced as ceased in the Patents Journal due to a failure to pay the 14th year renewal fee. The Office had however failed to process a notification of a change of address for service correctly which had resulted in the renewal reminder being sent to the wrong address. … Continue reading Charalambous (Patent): IPO 29 Nov 2010

The issue concerns whether the request to reinstate the application was filed within the time allowed by Rule 32(1) and if so should it then be reinstated under the provisions of Section 20A. The applicants failed to place the application in order for grant before the compliance period expired on 30 April 2013, so the … Continue reading Jiri George Frank Krizek and Jan David Krizek (Patent): IPO 14 Oct 2014

Disclosure and enablement are distinct concepts in patents law, each of which has to be satisfied and each of which has its own rules. As to sufficiency: ‘In my view, devising an invention and providing enabling disclosure are two quite different things. Although both may be necessary to secure valid protection, as section 14 of … Continue reading IDA Ltd and others v University of Southampton and others; University of Southampton’s Applications: Patc 28 Jul 2004

genzymeIPO102013 Supplementary Protection Certificate SPC/GB/04/031 was granted for colesevelam hydrochloride, the active ingredient in the medicinal product Cholestagel [RTM] used to treat hypercholesterolaemia. As part of a request for an extension to the period of protection provided by the granted SPC, the applicant requested that date of expiry for the term of protection of this … Continue reading Genzyme Corporation (Patent): IPO 22 Oct 2013